S&P 500   4,001.09 (-0.04%)
DOW   32,486.38 (-0.23%)
QQQ   311.07 (+0.24%)
AAPL   160.03 (+0.47%)
MSFT   277.05 (+1.19%)
META   204.05 (+0.93%)
GOOGL   105.30 (+0.36%)
AMZN   100.19 (-0.42%)
TSLA   196.31 (-0.64%)
NVDA   270.06 (+3.08%)
NIO   9.27 (+0.00%)
BABA   84.11 (+0.49%)
AMD   99.38 (+3.60%)
T   18.58 (+0.22%)
F   11.76 (+0.34%)
MU   59.00 (+0.63%)
CGC   1.95 (-1.07%)
GE   91.59 (-0.64%)
DIS   96.42 (-0.12%)
AMC   4.58 (+3.85%)
PFE   40.38 (-0.69%)
PYPL   75.63 (-1.42%)
NFLX   300.94 (-1.59%)
S&P 500   4,001.09 (-0.04%)
DOW   32,486.38 (-0.23%)
QQQ   311.07 (+0.24%)
AAPL   160.03 (+0.47%)
MSFT   277.05 (+1.19%)
META   204.05 (+0.93%)
GOOGL   105.30 (+0.36%)
AMZN   100.19 (-0.42%)
TSLA   196.31 (-0.64%)
NVDA   270.06 (+3.08%)
NIO   9.27 (+0.00%)
BABA   84.11 (+0.49%)
AMD   99.38 (+3.60%)
T   18.58 (+0.22%)
F   11.76 (+0.34%)
MU   59.00 (+0.63%)
CGC   1.95 (-1.07%)
GE   91.59 (-0.64%)
DIS   96.42 (-0.12%)
AMC   4.58 (+3.85%)
PFE   40.38 (-0.69%)
PYPL   75.63 (-1.42%)
NFLX   300.94 (-1.59%)
S&P 500   4,001.09 (-0.04%)
DOW   32,486.38 (-0.23%)
QQQ   311.07 (+0.24%)
AAPL   160.03 (+0.47%)
MSFT   277.05 (+1.19%)
META   204.05 (+0.93%)
GOOGL   105.30 (+0.36%)
AMZN   100.19 (-0.42%)
TSLA   196.31 (-0.64%)
NVDA   270.06 (+3.08%)
NIO   9.27 (+0.00%)
BABA   84.11 (+0.49%)
AMD   99.38 (+3.60%)
T   18.58 (+0.22%)
F   11.76 (+0.34%)
MU   59.00 (+0.63%)
CGC   1.95 (-1.07%)
GE   91.59 (-0.64%)
DIS   96.42 (-0.12%)
AMC   4.58 (+3.85%)
PFE   40.38 (-0.69%)
PYPL   75.63 (-1.42%)
NFLX   300.94 (-1.59%)
S&P 500   4,001.09 (-0.04%)
DOW   32,486.38 (-0.23%)
QQQ   311.07 (+0.24%)
AAPL   160.03 (+0.47%)
MSFT   277.05 (+1.19%)
META   204.05 (+0.93%)
GOOGL   105.30 (+0.36%)
AMZN   100.19 (-0.42%)
TSLA   196.31 (-0.64%)
NVDA   270.06 (+3.08%)
NIO   9.27 (+0.00%)
BABA   84.11 (+0.49%)
AMD   99.38 (+3.60%)
T   18.58 (+0.22%)
F   11.76 (+0.34%)
MU   59.00 (+0.63%)
CGC   1.95 (-1.07%)
GE   91.59 (-0.64%)
DIS   96.42 (-0.12%)
AMC   4.58 (+3.85%)
PFE   40.38 (-0.69%)
PYPL   75.63 (-1.42%)
NFLX   300.94 (-1.59%)
NASDAQ:QTRX

Quanterix - QTRX Stock Forecast, Price & News

$10.94
-0.86 (-7.29%)
(As of 03/22/2023 01:44 PM ET)
Add
Compare
Today's Range
$10.92
$11.98
50-Day Range
$10.55
$14.91
52-Week Range
$6.31
$31.33
Volume
66,784 shs
Average Volume
317,820 shs
Market Capitalization
$407.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.20

Quanterix MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
70.5% Upside
$19.20 Price Target
Short Interest
Healthy
2.35% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.40) to ($1.18) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.08 out of 5 stars

Medical Sector

469th out of 983 stocks

Analytical Instruments Industry

14th out of 28 stocks


QTRX stock logo

About Quanterix (NASDAQ:QTRX) Stock

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Receive QTRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quanterix and its competitors with MarketBeat's FREE daily newsletter.

QTRX Stock News Headlines

Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
Here's what Wall Street expects from Quanterix's earnings
Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
Quanterix’ Third Quarter 2022 Earnings Conference Call
See More Headlines
Receive QTRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quanterix and its competitors with MarketBeat's FREE daily newsletter.

QTRX Company Calendar

Last Earnings
3/06/2023
Today
3/22/2023
Next Earnings (Estimated)
5/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:QTRX
Fax
N/A
Employees
460
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$19.20
High Stock Price Forecast
$38.00
Low Stock Price Forecast
$12.00
Forecasted Upside/Downside
+64.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
6 Analysts

Profitability

Net Income
$-96,700,000.00
Pretax Margin
-91.58%

Debt

Sales & Book Value

Annual Sales
$105.52 million
Book Value
$9.69 per share

Miscellaneous

Free Float
34,195,000
Market Cap
$433.96 million
Optionable
Not Optionable
Beta
1.37

Key Executives

  • Masoud Toloue
    President, Chief Executive Officer & Director
  • Daniel Pikora
    Chief Operating Officer
  • Michael A. Doyle
    Chief Financial Officer
  • David C. DuffyDavid C. Duffy
    Chief Technology Officer & Vice President-Research
  • Samira Amini
    Chief of Staff & Senior Vice President













QTRX Stock - Frequently Asked Questions

Should I buy or sell Quanterix stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Quanterix in the last twelve months. There are currently 6 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" QTRX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QTRX, but not buy additional shares or sell existing shares.
View QTRX analyst ratings
or view top-rated stocks.

What is Quanterix's stock price forecast for 2023?

6 equities research analysts have issued 12-month target prices for Quanterix's shares. Their QTRX share price forecasts range from $12.00 to $38.00. On average, they expect the company's share price to reach $19.20 in the next twelve months. This suggests a possible upside of 62.7% from the stock's current price.
View analysts price targets for QTRX
or view top-rated stocks among Wall Street analysts.

How have QTRX shares performed in 2023?

Quanterix's stock was trading at $13.85 at the beginning of 2023. Since then, QTRX stock has decreased by 14.8% and is now trading at $11.80.
View the best growth stocks for 2023 here
.

When is Quanterix's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023.
View our QTRX earnings forecast
.

How were Quanterix's earnings last quarter?

Quanterix Co. (NASDAQ:QTRX) announced its quarterly earnings results on Monday, March, 6th. The company reported ($0.50) earnings per share for the quarter, topping the consensus estimate of ($0.53) by $0.03. The firm earned $25.82 million during the quarter, compared to the consensus estimate of $26.16 million. Quanterix had a negative net margin of 91.66% and a negative trailing twelve-month return on equity of 19.54%. During the same quarter last year, the firm earned ($0.55) EPS.

What ETFs hold Quanterix's stock?

ETFs with the largest weight of Quanterix (NASDAQ:QTRX) stock in their portfolio include Invesco Nasdaq Future Gen 200 ETF (QQQS), Principal Healthcare Innovators ETF (BTEC), iShares Biotechnology ETF (IBB).

What is Kevin Hrusovsky's approval rating as Quanterix's CEO?

15 employees have rated Quanterix Chief Executive Officer Kevin Hrusovsky on Glassdoor.com. Kevin Hrusovsky has an approval rating of 70% among the company's employees.

What other stocks do shareholders of Quanterix own?
When did Quanterix IPO?

(QTRX) raised $50 million in an initial public offering on Thursday, December 7th 2017. The company issued 3,300,000 shares at $14.00-$16.00 per share. J.P. Morga and Leerink Partners served as the underwriters for the IPO and BTIG and Evercore ISI were co-managers.

What is Quanterix's stock symbol?

Quanterix trades on the NASDAQ under the ticker symbol "QTRX."

Who are Quanterix's major shareholders?

Quanterix's stock is owned by many different institutional and retail investors. Top institutional investors include Millennium Management LLC (4.44%), Granahan Investment Management LLC (3.40%), Point72 Asset Management L.P. (2.94%), Deutsche Bank AG (2.77%), Platinum Investment Management Ltd. (2.71%) and Ashford Capital Management Inc. (2.62%). Insiders that own company stock include Amol Chaubal, David C Duffy, David C Duffy, David R Walt, Dawn Mattoon, E Kevin Hrusovsky, John J Fry, John J Fry, Marijn E Dekkers, Marijn E Dekkers, Mark T Roskey, Mark T Roskey, Martin D Madaus, Masoud Toloue and Michael A Doyle.
View institutional ownership trends
.

How do I buy shares of Quanterix?

Shares of QTRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Quanterix's stock price today?

One share of QTRX stock can currently be purchased for approximately $11.80.

How much money does Quanterix make?

Quanterix (NASDAQ:QTRX) has a market capitalization of $439.55 million and generates $105.52 million in revenue each year. The company earns $-96,700,000.00 in net income (profit) each year or ($2.61) on an earnings per share basis.

How many employees does Quanterix have?

The company employs 460 workers across the globe.

How can I contact Quanterix?

Quanterix's mailing address is 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821. The official website for the company is www.quanterix.com. The company can be reached via phone at (617) 301-9400 or via email at ir@quanterix.com.

This page (NASDAQ:QTRX) was last updated on 3/22/2023 by MarketBeat.com Staff